Interim Phase IIa Results for Spiegelmer® Olaptesed Pegol (NOX-A12) in CLL and MM Studies
NOXXON Pharma disclosed interim data from two independent clinical phase IIa studies of the anti-CXCL12/SDF-1 Spiegelmer…
NOXXON Pharma disclosed interim data from two independent clinical phase IIa studies of the anti-CXCL12/SDF-1 Spiegelmer…
The biotechnology company BRAIN AG congratulates their partner company MONTEIL Cosmetics International GmbH on receiving…
The German Fashion Institute will tomorrow name the winner of the 35th "Tie Wearer of the Year" award. This year's wi…
Today Projectplace, the European leader in online project collaboration, launched a new Project Overview with an integra…